Patrick Brossard

440 total citations
18 papers, 367 citations indexed

About

Patrick Brossard is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Patrick Brossard has authored 18 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Patrick Brossard's work include Sphingolipid Metabolism and Signaling (12 papers), Multiple Sclerosis Research Studies (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Patrick Brossard is often cited by papers focused on Sphingolipid Metabolism and Signaling (12 papers), Multiple Sclerosis Research Studies (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Patrick Brossard collaborates with scholars based in Switzerland, United States and Germany. Patrick Brossard's co-authors include Jasper Dingemanse, Haidar Maatouk, Atef Halabi, Daniele D’Ambrosio, Matthias Hoch, Hartmut Derendorf, Jian Xu, Andreas Krause, Michael W. Scherz and Frank Lüdicke and has published in prestigious journals such as British Journal of Clinical Pharmacology, European Journal of Pharmaceutical Sciences and Clinical Therapeutics.

In The Last Decade

Patrick Brossard

16 papers receiving 352 citations

Peers

Patrick Brossard
Valeria Simonelli Italy
Tanja Thybo Denmark
Elon C. Roti Roti United States
Marijke Schreuders‐Koedam Netherlands
Serena Scollen United Kingdom
Chun‐Yue I. Lee United States
Liping Wu China
Eui-Hwan Choi South Korea
Lixin Zhang Auberson Switzerland
Valeria Simonelli Italy
Patrick Brossard
Citations per year, relative to Patrick Brossard Patrick Brossard (= 1×) peers Valeria Simonelli

Countries citing papers authored by Patrick Brossard

Since Specialization
Citations

This map shows the geographic impact of Patrick Brossard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Brossard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Brossard more than expected).

Fields of papers citing papers by Patrick Brossard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Brossard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Brossard. The network helps show where Patrick Brossard may publish in the future.

Co-authorship network of co-authors of Patrick Brossard

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Brossard. A scholar is included among the top collaborators of Patrick Brossard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Brossard. Patrick Brossard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Brossard, Patrick & Christian Laveille. (2024). Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis. Rheumatology and Therapy. 11(3). 869–880. 1 indexed citations
3.
Toutain, Céline E., et al.. (2018). Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations. BMC Veterinary Research. 14(1). 242–242. 6 indexed citations
4.
Brossard, Patrick, Rolf Weitkunat, Nicola Lama, et al.. (2017). Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers. Regulatory Toxicology and Pharmacology. 89. 193–199. 38 indexed citations
5.
Marchand, Mathilde, Patrick Brossard, Henri Merdjan, et al.. (2017). Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis. European Journal of Drug Metabolism and Pharmacokinetics. 42(6). 943–954. 15 indexed citations
6.
Brossard, Patrick, Larissa Sandalic, Mikael Franzon, et al.. (2017). Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System. Nicotine & Tobacco Research. 20(4). 458–465. 8 indexed citations
7.
Scherz, Michael W., et al.. (2015). Three different up-titration regimens of ponesimod, an S1P1receptor modulator, in healthy subjects. The Journal of Clinical Pharmacology. 55(6). 688–697. 19 indexed citations
8.
Hoch, Matthias, et al.. (2014). Mass balance, pharmacokinetics and metabolism of the selective S1P1receptor modulator ponesimod in humans. Xenobiotica. 45(2). 139–149. 15 indexed citations
9.
10.
D’Ambrosio, Daniele, Jörg Steinmann, Patrick Brossard, & Jasper Dingemanse. (2014). Differential effects of ponesimod, a selective S1P1receptor modulator, on blood-circulating human T cell subpopulations. Immunopharmacology and Immunotoxicology. 37(1). 103–109. 20 indexed citations
11.
Hoch, Matthias, Daniele D’Ambrosio, Darren Wilbraham, Patrick Brossard, & Jasper Dingemanse. (2014). Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects. European Journal of Pharmaceutical Sciences. 63. 147–153. 25 indexed citations
12.
Krause, Andreas, Patrick Brossard, Daniele D’Ambrosio, & Jasper Dingemanse. (2014). Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator. Journal of Pharmacokinetics and Pharmacodynamics. 41(3). 261–278. 21 indexed citations
13.
Brossard, Patrick, Michael W. Scherz, Atef Halabi, et al.. (2014). Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1receptor modulator: Favorable impact of dose up-titration. The Journal of Clinical Pharmacology. 54(2). 179–188. 58 indexed citations
14.
Hoch, Matthias, Börje Darpö, Patrick Brossard, et al.. (2014). Effect of Ponesimod, a Selective S1P1 Receptor Modulator, on the QT Interval in Healthy Individuals. Basic & Clinical Pharmacology & Toxicology. 116(5). 429–437. 18 indexed citations
15.
Brossard, Patrick, et al.. (2013). Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive. European Journal of Clinical Pharmacology. 70(3). 287–293. 15 indexed citations
16.
Hoch, Matthias, Andrea Vaclavkova, R Stoltz, Patrick Brossard, & Jasper Dingemanse. (2013). PP162—Thorough QT study with ponesimod, a selective S1P1 receptor modulator. Clinical Therapeutics. 35(8). e68–e69. 1 indexed citations
17.
Hoch, Matthias, Daniele D’Ambrosio, Darren Wilbraham, Patrick Brossard, & Jasper Dingemanse. (2013). Oc015—Up-Titration Study With Ponesimod, A Selective S1p1 Receptor Modulator, To Assess Its Maximum Tolerated Dose In Healthy Subjects. Clinical Therapeutics. 35(8). e6–e7. 1 indexed citations
18.
Brossard, Patrick, Hartmut Derendorf, Jian Xu, et al.. (2013). Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first‐in‐human study. British Journal of Clinical Pharmacology. 76(6). 888–896. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Simonelli Breakdown of academic impact, for papers by Tanja Thybo Breakdown of academic impact, for papers by Elon C. Roti Roti Breakdown of academic impact, for papers by Marijke Schreuders‐Koedam Breakdown of academic impact, for papers by Serena Scollen Breakdown of academic impact, for papers by Chun‐Yue I. Lee Breakdown of academic impact, for papers by Liping Wu Breakdown of academic impact, for papers by Eui-Hwan Choi Breakdown of academic impact, for papers by Lixin Zhang Auberson
Rankless by CCL
2026